Senseonics Holdings, Inc.
NASDAQ:SENSMedical - Devices
-$0.09 today
- Market cap
- $533.56M
- Beta
- 0.97
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$1.90
Volume 0.87M
Average 0.71M
SENS Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Senseonics Holdings, Inc.NASDAQ: SENS
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation growth accelerates
Q1 FY2026 stock-based compensation of $2.28M rose 23.7% year over year, ahead of the +14.3% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 13.3% from the prior quarter. Over 3 fiscal years it compounded at +5.6% a year.
Context
- Stock-based compensation amounted to 28.8% of revenue in FY2025, down 12.3 pp from a year earlier.
- Stock-based compensation increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +23.7% holds above the trailing-twelve-month pace of +14.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 10.15M USD
- Year-over-year change
- +10.1%
- 4-year CAGR
- +3.0%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.15M | +10.1% |
| FY2024 | 2024-12-31 | 9.23M | +6.4% |
| FY2023 | 2023-12-31 | 8.67M | +0.6% |
| FY2022 | 2022-12-31 | 8.62M | -4.6% |
| FY2021 | 2021-12-31 | 9.03M | — |
Stock-Based Compensation vs competitors
How SENS compares with its peers on the latest reported figures
- SENS's LTM Mar 2026 stock-based compensation of $10.59M is the smallest of the 6 companies compared; the peer median is $77.9M.
- Its year-over-year change of +14.3% is the 3rd highest of 5, against a peer median of +9.9%.
- Stock-based compensation amounts to 26.0% of revenue for SENS, versus a peer median of 3.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $162.4M | -2.3% | +8.1% | 3.3% | |
| LTM Mar 2026 | $82.55M | -21.3% | +2.8% | 8.0% | |
| LTM Jun 2026 | $77.9M | +22.1% | +15.3% | 2.6% | |
MMEDMiniMed Group, Inc. Common Stock | LTM Jul 2026 | $47M | — | +9.5% | 1.5% |
| LTM Mar 2026 | $18.99M | +142.5% | +39.0% | 17.2% | |
| LTM Mar 2026 | $10.59M | +14.3% | +5.6% | 26.0% | |
| Peer median (excluding SENS) | $77.9M | +9.9% | +9.5% | 3.3% | |
Competitors are the stored peer set for SENS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (302.47M) | 142.12M | (60.39M) | (78.62M) | (69.11M) |
| Depreciation & Amortization | 1.24M | 985K | 1.28M | 1.48M | 91K |
| Deferred Income Tax | 229.17M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 9.03M | 8.62M | 8.67M | 9.23M | 10.15M |
| Change in Working Capital | (1.5M) | (2.47M) | (3.97M) | 865K | (3.28M) |
| Accounts Receivables | 1.01M | (478K) | (2.19M) | (2.7M) | (6.77M) |
| Inventory | (1.04M) | (989K) | (1.64M) | 696K | (2.98M) |
| Accounts Payables | (559K) | (785K) | 2.3M | (1.83M) | 1.22M |
| Other Working Capital | (922K) | (219K) | (2.43M) | 4.7M | 5.24M |
| Other Non-Cash Items | 8.46M | (215.56M) | (15.76M) | 6.59M | 3.02M |
| Operating Cash Flow | (56.08M) | (66.31M) | (70.16M) | (60.47M) | (59.13M) |
| Capital Expenditures | (210K) | (312K) | (350K) | (2.24M) | (1.12M) |
| Acquisitions (Net) | 210K | (27.19M) | 0 | 0 | 0 |
| Purchases of Investments | (154.51M) | (104.71M) | (68.54M) | (58.02M) | (100.69M) |
| Sales of Investments | 5.98M | 131.9M | 158.6M | 93.1M | 48.39M |
| Other Investing Activities | (210K) | 27.19M | 0 | 0 | 0 |
| Investing Cash Flow | (148.75M) | 26.88M | 89.71M | 32.84M | (53.42M) |
| Debt Repayment | (2.84M) | (2.93M) | 1.25M | 9.95M | (20.4M) |
| Common Stock Issued | 200.37M | 34.17M | 7.38M | 18.36M | 100.73M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (227K) | (1.49M) | 11.74M | (1.48M) | (2.15M) |
| Financing Cash Flow | 220.08M | 41.76M | 20.37M | 26.83M | 78.19M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 15.26M | 2.33M | 39.92M | (797K) | (34.36M) |
| Free Cash Flow | (56.29M) | (66.62M) | (70.51M) | (62.7M) | (60.25M) |
Senseonics Holdings, Inc.
NASDAQ:SENS
Intrinsic Alpha fair value
Locked
Current Price
$9.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.